Ken Garber
In a Major Shift, Cancer Drugs Go ‘Tissue-Agnostic’
Encouraged by an FDA approval, companies design cancer drugs to work in any solid tumor
Science, 2017
What's inside?
Novel drugs defeat cancer cells by targeting their flaws like magic bullets.